2010年6月期第2四半期連結業績報告書

This document is a report on the consolidated financial results for the second quarter of the fiscal year ending June 2010. The total sales reached 27.822 billion yen, representing a 4% increase compared to the same period last year, while ordinary profit was 900 million yen and quarterly net profit was 350 million yen, indicating overall growth in revenue and profit. The medical equipment business remains the main source of income, with strong sales in the cardiovascular, orthopedic, and surgical materials segments. The life sciences segment recorded a significant 23% increase compared to the previous year, although it continues to face operating losses. The company aims to expand into new segments and regions, focusing on generic pharmaceuticals, POCT kits, and sales of imaging diagnostic equipment.